Skip to main content
. 2023 Jun 29;14:1193608. doi: 10.3389/fpsyg.2023.1193608

Table 1.

Baseline characteristics of patients.

Characteristic Patients, No./Total No. (%)/Mean ± SD t122/Z3 p-value
Control group (n = 52) VR group (n = 55)
Age, Mean ± SD 64.8 ± 11. 3 65.2 ± 10. 0 −0.2001 0.843
Sex, No. (%) 0.7282 0.402
Men 44 (84.6) 43 (78.2)
Women 8 (15.4) 12 (21.8)
Residential area, No. (%) 1.8302 0.400
Urban 27 (51.9) 30 (54.5)
Town 4 (7.7) 8 (14.5)
Countryside 21 (40.4) 17 (30.9)
Educational level, No. (%) −0.6453 0.528
Primary school or below 14 (26.9) 16 (29.1)
Junior/Vocational school 33 (63.5) 27 (49.1)
College 3 (5.8) 10 (18.2)
Graduate school 2 (3.8) 2 (3.6)
Annual household income,¥ −1.0493 0.291
≤50,000 9 (17.3) 6 (10.9)
60,000–100,000 16 (30.8) 15 (27.3)
110,000–200,000 22 (42.3) 28 (50.9)
>200,000 5 (9.6) 6 (10.9)
Disease duration, m −0.9683 0.336
<1 18 (34.6) 19 (34.5)
1–6 20 (38.5) 15 (27.3)
7–12 6 (11.5) 3 (5.5)
>12 8 (15.4) 18 (32.7)
Co-morbidities, No. (%) 1.5622 0.254
Coronary heart disease 8 (15.4) 9 (16.4)
Hypertension 30 (57.7) 36 (65.5)
Diabetes mellitus 16 (30.8) 14 (25.5)
Malignant tumor 2 (3.8) 2 (3.4)
Other serious diseases 9 (17.3) 12 (21.8)
None 12 (23.1) 13 (23.6)
aPSQI score, Mean ± SD 9.19 ± 3.59 9.25 ± 3.26 −0.0861 0.931
Anesthesia, No. (%) 1.8522 0.176
Local anesthesia 39 (75.0) 47 (85.5)
General anesthesia 13 (25.0) 8 (14.5)
Number of stents, No. (%) 0.0033 0.965
Just 1 39 (75.0) 41 (74.5)
2 or more 3 (25.0) 14 (25.5)
STAIb Pre-intervention
S-AI 48.9 ± 9.5 47.9 ± 10.5 0.0081 0.993
T-AI 46.9 ± 9.9 46.7 ± 11.7 0.1111 0.915
SEMCD-6c Pre-intervention
DSM 4.27 ± 0.83 4.18 ± 0.95 0.5561 0.583
DCM 2.07 ± 0.48 2.08 ± 0.43 −0.1931 0.854
Total 6.33 ± 1.22 6.27 ± 1.13 0.2931 0.772
a

PSQI, Pittsburgh sleep quality index.

b

STAI, State–trait anxiety inventory, containing state anxiety inventory (S-AI) and trait anxiety inventory (T-AI).

c

SEMCD-6, Self-efficacy for managing chronic disease, composed of disease symptom management (DSM, items 1–4) and disease co-occurrence management (DCM, items 5–6).

VR, virtual reality.